SAT-198 ASC41, a selective THRβ agonist significantly reduces liver fat and ALT in biopsy-confirmed MASH patients after 12-week treatment: an interim analysis of a 52-week serial liver biopsy study.

Details

Language :

English

ISSN :

01688278

Volume :

80

Database :

Academic Search Index

Journal :

Journal of Hepatology

Publication Type :

Academic Journal

Accession number :

177654607

Full Text :

https://doi.org/10.1016/S0168-8278(24)01768-9